Home / Inspections / 1017684

FDA Inspection 1017684 — Olexiy Sagan, MD

Olexiy Sagan, MD — FEI 3013322552

The FDA completed an inspection of Olexiy Sagan, MD on Jun 9, 2017 in Zaporizhzhia. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 9, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Zaporizhzhia (Ukraine)

Additional details

Clinical Investigator (CI)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.